CRO Newsletter May 2008
Introducing Applied Clinical Trials’ new enewsletter, CRO News, which provides a forum for the industry to discuss the latest alliances, financial information, and business deals and developments, as well as people news.
Premier Research Group and Octagon Research Solutions
Premier Research Group, a Philadelphia-based CRO, and Octagon Research Solutions a electronic solutions provider based in Wayne, PA, announced in late April the companies' formal intent to combine Octagon's electronic submissions capability with Premier's expertise across therapeutic areas. Each company will partner to offer the other's capabilities to its respective clients.
>>
Clinsys Freshens Up Its Services
Within the span of two days, Clinsys Clinical Research announced two strategic moves. The Bedminster, NJ-based, therapeutically-focused CRO introduced its Therapeutically-aligned Program Strategists. These teams consist of MDs, PhDs, and a clinical operations program director with expertise in a specific therapeutic area. Its second announcement was the launch of Clinsys ALTERNA, billed on its Web site as providing customized Phase I through IV clinical trial alternative solutions.
>>
CRO Goes Green
At ProTrials, the environment is an important issue, and one that employees support. Read more about how the Mountain View, CA-based CRO initiates green policies in this interview with co-founder and president Inger Arum.
Axiom Accelerated Patient Recruitment
Partner with Axiom Accelerated Patient Recruitment to develop customized recruitment initiatives that motivate qualified patients. Leave Patient Recruitment To The Experts. Visit:
May 19–21, 2008
Location | Washington, DC
May 21–22 , 2008
Location | London, UK
May 29–30 , 2008
Location | Tokyo, Japan
"A Quick Guide to Clinical Trials" was recently unveiled. The book was edited by Dr. Madhu Davies and Dr. Faiz Kermani. Click
Check out the CRO + EDC Special Report from ClinPage for insights into this group dynamic. Part III is
We're looking forward to the outcomes from the Post-Approval Summit being held at Harvard Medical School today and tomorrow. Link
Increasingly complex protocol design is negatively impacting clinical trials, and a new study confirms it. Read Ken Getz's column about it
You are subscribed to %%list.name%% as %%emailaddr%%. To unsubscribe from this list
To ensure delivery to your Inbox, please add %%email.list%% to your address book. If you need help doing this,
Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 1-866-529-2922 at any time, or fax us at 1-218-740-6417. Outside the U.S., please phone 1-218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Articles
- How the NIMBLE Study Supported Adherence With Quarterly Dosing of Cemdisiran
September 18th 2025
- Everything to Know About FDA’s Push Towards Radical Transparency in 2025
September 17th 2025